Tarlatamab Shows Promise in Tackling Previously Treated SCLC : vimarsana.com

The investigational drug led to encouraging overall survival and intracranial disease control in patients with small-cell lung cancer, longer-term trial data suggested.

Related Keywords

London , City Of , United Kingdom , Mainfranken , Bayern , Germany , Italy , Horst Dieter Hummel , Tom Newsom Davis , Cancer Center Mainfranken , European Lung Cancer Congress , Comprehensive Cancer Center Mainfranken , Jessica Menis , Oncology Department , University Hospital , Westminster Hospital ,